Lake Mary, Florida (PRWEB) May 07, 2014
Axium Healthcare Pharmacy (http://www.axiumhealthcare.com) announced today that it has been accepted into the GlaxoSmithKline (GSK) Oncology network. As a GSK-authorized specialty pharmacy, Axium will expand its long-standing oncology therapy management focus with the addition of the following GSK oral oncology specialty medications:
“We are pleased to be a part of the GSK Oncology Network,” said Axium Healthcare Pharmacy President and CEO, Mark Montgomery. “For years, Axium Healthcare Pharmacy’s OncologyVisions® program has made it easier for patients and providers around the country to achieve better outcomes in cancer care. As an authorized GSK Oncology Network specialty pharmacy, Axium is well-positioned to provide practices and patients with the highly-personalized care, clinical support and ongoing patient management we’ve become known for.”
Prescribing information for the aforementioned GSK oral oncology specialty medications can be found online at http://www.gsksource.com.
About Axium Healthcare Pharmacy
Founded in 2000, Axium Healthcare Pharmacy, Inc. is a nationwide provider of specialty pharmacy services. A wholly-owned subsidiary of The Kroger Company, Axium provides drug therapies and patient support services to treat chronic, genetic, and other complex conditions such as Hepatitis C, Multiple Sclerosis, Cancer, Rheumatoid Arthritis, and a number of others.
For more information, contact Axium Healthcare Pharmacy at 888.315.3395 or visit http://www.axiumhealthcare.com.
GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information, please visit http://www.gsk.com.